Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

“Illumina’s newest distributable IVD kit for comprehensive genomic profiling and accompanying ... About TruSight Oncology Comprehensive TruSight Oncology Comprehensive is a qualitative in vitro ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...

The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...

They expect sales of Fluent’s kits to rise significantly ... rather than competing with diagnostics companies like Grail. Souda wrote that the deal will help Illumina grab more of the research ...

Illumina is an applied genomics technology company that was founded in 1998 with the mission statement: ‘To improve human health by unlocking the power of the genome’. Over the past two ...

Consumables, such as sequencing kits for specific genomes, are the main revenue driver with over 70% revenue contribution. We expect strong consumables growth as customers transition to Illumina ...